Pure Global AI
NCT05626647Completed

Etiology of Anemia Among Preschool Children in Ethiopia

Etiology of Anemia Among Preschool Children and Its Public Health Implication in Selected Regions of Ethiopia: A Community-Based Longitudinal Study
Oklahoma State UniversityClinicalTrials.gov
Study focus
Disease/Condition
Anemia
Study type
Observational
Sponsor & location
Primary sponsor
Oklahoma State University
Location
Addis Ababa, Ethiopia
Timeline & enrollment
Phase
N/A
Start date
Nov 01, 2021
End date
Sep 04, 2022
Enrollment
590 participants
Primary outcome

Prevalence of anemia among preschool children in selected regions of Ethiopia in the two different (Post and Pre harvest) seasons?

Summary

This study aims to determine the etiology of anemia among preschool children in selected
 regions of Ethiopia. The study is a longitudinal observational study to assess the
 determinant factors of anemia in two different seasons.
 
 The main questions it aims to answer are:
 
 1. What is the prevalence and etiology of anemia in the two different (Post and
 Pre-harvest) seasons?
 
 2. What is the strength of the interaction between anemia and each of the determinant
 factors being considered?
 
 The participant's dietary intake and anthropometric measurement have been assessed, and
 biological samples (Blood and Stool) were collected to determine the prevalence of anemia and
 the factors contributing to it.

ICD-10 classifications
Anaemia, unspecifiedOther anaemiasOther specified anaemiasIron deficiency anaemiaIron deficiency anaemia, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05626647
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05626647 through Pure Global AI's free database. This phase not specified trial is sponsored by Oklahoma State University and is currently Completed. The study focuses on Anemia. Target enrollment is 590 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.